Statistics for Repare Therapeutics Inc (id:8058 RPTX)

Valuation metrics

Market cap

138.16M

Enterprise value

-38,709,200.00

Trailing P/E (ttm)

-1.26

Forward P/E

-1.09

PEG ratio

-1.09

Price/Sales (ttm)

2.08

Price/Book (mrq)

0.79

Enterprise Value/Revenue

-0.58

Enterprise Value/EBITDA

0.43

Overview

Shares outstanding

42.51M

Float

20.17M

Shares short

749.74K

% Held by insiders

0.01%

% Held by institutions

0.87%

Average volume (10 days)

98.77K

Average volume (90 days)

Price summary

52-Week low

2.71

52-Week high

8.49

52-Week change

-71.53%

Beta

0.71

50-Day moving average

3.39

200-Day moving average

4.02

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-126.34%

Operating margin

-138.62%

Operational effectiveness

Return on assets

-23.39%

Return on equity

-41.17%

Income statement

Revenue (ttm)

1.57

Revenue per share (ttm)

1.57

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-90,242,000.00

Net income to common (ttm)

-84,048,000.00

Diluted EPS (ttm)

-1.62

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

179.43M

Total cash per share (mrq)

4.22

Total debt (mrq)

2.56M

Total Debt/Equity (mrq)

1.46

Current ratio (mrq)

644.70%

Book value per share (mrq)

4.12

Cash flow

Cash flow statement

-77,277,000.00

Levered free cash flow (LFCF)

-45,180,376.00